Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Clinical trial NCT00730288 · COMPLETED

Trial details

NCT number: NCT00730288
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dengue Dengue Fever Dengue Hemorrhagic Fever Dengue Virus

Start date: 2006-08-01
Primary completion: 2007-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.